Cargando…

Immunotherapeutic early-phase clinical trials and malignant gliomas: A single-center experience and comprehensive immunophenotyping of circulating leukocytes

BACKGROUND: Immunotherapeutic early-phase clinical trials (ieCTs) increasingly adopt large expansion cohorts exploring novel agents across different tumor types. High-grade glioma (HGG) patients are usually excluded from these trials. METHODS: Data of patients with recurrent HGGs treated within mult...

Descripción completa

Detalles Bibliográficos
Autores principales:	Simonelli, Matteo, Persico, Pasquale, Capucetti, Arianna, Carenza, Claudia, Franzese, Sara, Lorenzi, Elena, Dipasquale, Angelo, Losurdo, Agnese, Giordano, Laura, Pessina, Federico, Navarria, Pierina, Politi, Letterio S, Mavilio, Domenico, Locati, Massimo, Della Bella, Silvia, Santoro, Armando, Bonecchi, Raffaella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Clinical Investigations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8661084/ https://www.ncbi.nlm.nih.gov/pubmed/34901858 http://dx.doi.org/10.1093/noajnl/vdab160

Ejemplares similares

Checkpoint Inhibitors as High-Grade Gliomas Treatment: State of the Art and Future Perspectives
por: Persico, Pasquale, et al.
Publicado: (2021)

Precision Oncology in Lower-Grade Gliomas: Promises and Pitfalls of Therapeutic Strategies Targeting IDH-Mutations
por: Persico, Pasquale, et al.
Publicado: (2022)

Perioperative corticosteroid treatment impairs tumor-infiltrating dendritic cells in patients with newly diagnosed adult-type diffuse gliomas
por: Carenza, Claudia, et al.
Publicado: (2023)

Role of 11C Methionine Positron Emission Tomography (11CMETPET) for Surgery and Radiation Therapy Planning in Newly Diagnosed Glioblastoma Patients Enrolled into a Phase II Clinical Study
por: Pessina, Federico, et al.
Publicado: (2021)

Neutrophils in Gliomas
por: Massara, Matteo, et al.
Publicado: (2017)

Conducting Phase I Trials During the SARS-Coronavirus-2 Outbreak: About Science and Care
por: Dipasquale, Angelo, et al.
Publicado: (2020)

COVID-19 lung injury as a primer for immune checkpoint inhibitors (ICIs)-related pneumonia in a patient affected by squamous head and neck carcinoma treated with PD-L1 blockade: a case report
por: Dipasquale, Angelo, et al.
Publicado: (2021)

Natural Killer–Dendritic Cell Interactions in Liver Cancer: Implications for Immunotherapy
por: Cazzetta, Valentina, et al.
Publicado: (2021)

Multiple Roles for Chemokines in Neutrophil Biology
por: Capucetti, Arianna, et al.
Publicado: (2020)

Immunotherapeutic implications of the immunophenotype of pediatric brain tumors
por: Griesinger, Andrea M, et al.
Publicado: (2014)

Leukocyte immunophenotyping: methodological aspects
por: Jämsä, J, et al.
Publicado: (2010)

Chemokines and Chemokine Receptors: New Targets for Cancer Immunotherapy
por: Mollica Poeta, Valeria, et al.
Publicado: (2019)

Preoperative [(11)C]methionine PET to personalize treatment decisions in patients with lower-grade gliomas
por: Ninatti, Gaia, et al.
Publicado: (2022)

Tumor Immunophenotyping‐Derived Signature Identifies Prognosis and Neoadjuvant Immunotherapeutic Responsiveness in Gastric Cancer
por: Wang, Jia‐Bin, et al.
Publicado: (2023)

Polystyrene microspheres enable 10‐color compensation for immunophenotyping of primary human leukocytes
por: Byrd, Tiara, et al.
Publicado: (2015)

Human Leukocyte Antigen Alleles Compatibility and Immunophenotypic Profile Associations in Infertile Couples
por: Oikonomou, Georgia, et al.
Publicado: (2023)

The efficacy of Stereotactic body radiation therapy and the impact of systemic treatments in oligometastatic patients from prostate cancer
por: Franzese, Ciro, et al.
Publicado: (2018)

Can advanced new radiation therapy technologies improve outcome of high grade glioma (HGG) patients? analysis of 3D-conformal radiotherapy (3DCRT) versus volumetric-modulated arc therapy (VMAT) in patients treated with surgery, concomitant and adjuvant chemo-radiotherapy
por: Navarria, Pierina, et al.
Publicado: (2016)

Immunophenotype
por: Albani, Salvatore
Publicado: (2014)

Costimulatory Molecules and Immune Checkpoints Are Differentially Expressed on Different Subsets of Dendritic Cells
por: Carenza, Claudia, et al.
Publicado: (2019)

Hematological and biochemical profiles of canine CD45(−) T lymphomas are different from other immunophenotypes
por: Sánchez-Solé, Rosina, et al.
Publicado: (2021)

Immunophenotyping and activation status of maternal peripheral blood leukocytes during pregnancy and labour, both term and preterm
por: Zhang, Jianhong, et al.
Publicado: (2017)

Multimodality therapy approaches, local and systemic treatment, compared with chemotherapy alone in recurrent glioblastoma
por: Scorsetti, Marta, et al.
Publicado: (2015)

Intensity modulated proton therapy compared to volumetric modulated arc therapy in the irradiation of young female patients with hodgkin’s lymphoma. Assessment of risk of toxicity and secondary cancer induction
por: Scorsetti, Marta, et al.
Publicado: (2020)

The Radiology Department during the COVID-19 pandemic: a challenging, radical change
por: Politi, Letterio S., et al.
Publicado: (2020)

EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes
por: van Dongen, J J M, et al.
Publicado: (2012)

The radiologist empowerment through virtual multidisciplinary tumor boards: The commitment of oncologic care during COVID-19 pandemic
por: Gennaro, Nicolò, et al.
Publicado: (2021)

Novel Immunotherapeutic Strategies of Gastric Cancer Treatment
por: Amedei, Amedeo, et al.
Publicado: (2011)

A robust pipeline for high-content, high-throughput immunophenotyping reveals age- and genetics-dependent changes in blood leukocytes
por: Liechti, Thomas, et al.
Publicado: (2023)

Are three weeks hypofractionated radiation therapy (HFRT) comparable to six weeks for newly diagnosed glioblastoma patients? Results of a phase II study
por: Navarria, Pierina, et al.
Publicado: (2017)

The use of flow cytometry for diagnosis and immunophenotyping in chronic lymphocytic leukemia in a dog: Clinical case report
por: Sánchez-Solé, Rosina, et al.
Publicado: (2022)

Microglia immunophenotyping in gliomas
por: Annovazzi, Laura, et al.
Publicado: (2018)

CXCL4 and CXCL4L1 Differentially Affect Monocyte Survival and Dendritic Cell Differentiation and Phagocytosis
por: Gouwy, Mieke, et al.
Publicado: (2016)

Editorial: Untangling post-treatment follow up of brain tumors: the role of neuroimaging
por: Anzalone, Nicoletta, et al.
Publicado: (2023)

Standardizing Flow Cytometry Immunophenotyping Analysis from the Human ImmunoPhenotyping Consortium
por: Finak, Greg, et al.
Publicado: (2016)

Liquid Biopsy of Cerebrospinal Fluid Enables Selective Profiling of Glioma Molecular Subtypes at First Clinical Presentation
por: Orzan, Francesca, et al.
Publicado: (2023)

Multimodal Treatments for Brain Metastases from Renal Cell Carcinoma: Results of a Multicentric Retrospective Study
por: Navarria, Pierina, et al.
Publicado: (2023)

Control of Cytoskeletal Dynamics by β-Arrestin1/Myosin Vb Signaling Regulates Endosomal Sorting and Scavenging Activity of the Atypical Chemokine Receptor ACKR2
por: Vacchini, Alessandro, et al.
Publicado: (2020)

Outcome Evaluation of Oligometastatic Patients Treated with Surgical Resection Followed by Hypofractionated Stereotactic Radiosurgery (HSRS) on the Tumor Bed, for Single, Large Brain Metastases
por: Pessina, Federico, et al.
Publicado: (2016)

Advanced immunophenotyping: more is better!
por: Baumgarth, N
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_jhh843c9fau7otsilcjrnp0eek